P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials

• Simonetta Viviani,
• Chiara Pavoni,
• Sally F. Barrington,
• Luca Guerra,
• Heiko Schöder,
• Peter Johnson,
• Amy A. Kirkwood,
• Deborah M. Stephens,
• Jonathan W. Friedberg,
• Stephane Chauvie,
• Michael V. Knopp,
• Massimo Federico,
• Gunilla Enblad,
• Paolo Corradini,
• Andrea Gallamini,
• Alessandro Rambaldi,
• Corrado Tarella

Affiliations

Simonetta Viviani

1 Division of Onco-Hematology, European Institute of Oncology, IRCCS, Milan

Chiara Pavoni

3 Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

Sally F. Barrington

4 King’s College London and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences, King’s College London, King’s Health Partners, London.

Luca Guerra

5 School of Medicine and Surgery, University of Milano-Bicocca

Heiko Schöder

7 Memorial Sloan Kettering Cancer Center, New York, NY,USA

Peter Johnson

8 Cancer Research UK Centre, University of Southampton, UK.

Amy A. Kirkwood

9 Cancer Research UK and University College London Cancer Trials Centre, University College London, London

Deborah M. Stephens

10 Division of Hematology, University of Utah, Salt Lake City, UT.

Jonathan W. Friedberg

11 Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY.

Stephane Chauvie

12 Medical Physics Division, Santa Croce e Carle Hospital, Cuneo, Italy

Michael V. Knopp

13 Department of Radiology, Wright Center of Innovation in Biomedical Imaging, The Ohio State University Wexner Medical Center, Columbus, USA

Massimo Federico

14 CHIMOMO department, University of Modena and Reggio Emilia, Policlinico, Modena, Italy

Gunilla Enblad

15 Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory C11, Uppsala, Sweden

Paolo Corradini

2 Ematologia, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan

Andrea Gallamini

17 Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France

Alessandro Rambaldi

18 Ematologia, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

Corrado Tarella

20 Division of Onco-Hematology, European Institute of Oncology, IRCCS, Milan: Dipartimento Universitario di Scienze della Salute (DISS), Universita’ di Milano, Italy